Skip to content
Screener

Precigen PGEN Net margin

Net margin at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
18.9%+8.4pp
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
27.9%-3.5pp
Gilead Sciences logo
Gilead SciencesGILD
-10.6%-32.5pp
Allogene Therapeutics logo
Allogene TherapeuticsALLO
-1,170,863.6%-2,007,890pp
Regenxbio logo
RegenxbioRGNX
-112.6%-0.1pp
Opko Health logo
Opko HealthOPK
-12.4%-4.3pp

Other financials

Income statement

See full
Revenue$23.3M+1,634%
Operating income-$6.0M+73.5%
Net income-$7.9M+85.4%
EPS (diluted)-$0.02+88.9%

Balance sheet

See full
Cash & equivalents$7.5M+23.5%
Total debt$98.3M+1,714%
Total equity$20.2M+244%
Total assets$138.6M+7.6%

Cash flow

See full
Operating cash flow-$43.8M-168%
CapEx$258.0K-58.5%
Free cash flow-$44.1M-160%

Valuation

See full
Market cap$2.47B+358%
Enterprise value$2.56B+382%
P/S93.2×—

Profitability

See full
Gross margin83.6%—
Operating margin-2,890.9%—
FCF margin-1,756.5%—

Returns & leverage

See full
Return on equity-843.6%-1,103pp
Debt / equity4.9×—
Current ratio4.8×+1.3×

Where this comes from

Calculated from Precigen’s reported figures.

net income/total revenue=-3,656%

Based on trailing twelve months.

The source filing: Precigen’s 10-Q, filed May 13, 2026. Open the filing →

Filed
May 13, 2026, 4:20 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001356090-26-000017

FAQ

What is Precigen's net margin?
Precigen (PGEN) reported net margin of -3,656% in Q1 2025.
What is the long-term trend for Precigen's net margin?
Over 2 years (2020 to 2024), Precigen's net margin has grown at a 341.1% compound annual growth rate (CAGR), from -165.3% to -3,216.2%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.

Ask your AI about Precigen's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude